POET Could Be Worth More Staying Independent

POET Doesn't Need To Be Bought, And That Might Matter More

Wall Street is busy penciling in takeover bids for POET Technologies, but the bigger story may be that management does not need a buyer. With roughly $300 million in cash, production partnerships ramping, and a Lightwave Innovation award for its Teralight product, POET could be building a platform hyperscalers will pay to use, not buy outright.

Why the market is salivating

The optical M&A wave has made everyone look for the next takeover target. Marvell paid $3.25 billion for Celestial AI, and that deal has analysts guessing who will be next on the auction block.

POET $POET frequently sits near the top of those lists because its optical interposer technology promises to reduce cost, power and complexity for co-packaged optics. That makes it an attractive asset for switch makers, AI compute vendors and cloud hyperscalers racing to deploy co-packaged optics at scale.

But POET is not cash-starved

POET's balance sheet is a key counterargument to a fire sale. The company reports about $300 million in cash, a runway many small-cap semiconductor plays would envy.

That cash cushion gives POET optionality, from scaling production with partners to pursuing a licensing model rather than an exit. For companies with a real platform opportunity, optionality can be the most valuable asset of all.

Production partners and real sample volumes

Two partnerships matter here. POET's work with LITEON and Lessengers is not just PR, it's production-focused. Management says those partners expect to deliver samples for a 1.6T transceiver module, with samples expected in Q2 2026, a volume figure that signals movement from lab demos to real hardware.

Samples in the trillions are an odd metric, but in photonics more samples equals faster qualification cycles at hyperscalers and OEMs. Faster qualification can translate into earlier design wins and recurring revenue streams.

Teralight, awards, and momentum

POET's Teralight product recently won a Lightwave Innovation award, a signal that the optics community recognizes the tech. Awards don't pay invoices, but they do catalyze OEM interest and validation during vendor selection.

Combine that recognition with growing sample volume and you have a company that could be moving from IP and prototypes into an addressable market opportunity at a hyperscale pace.

The ARM analogy

Here's the central thesis: POET's optical interposer could become the ARM of photonics, a neutral platform that multiple vendors license or integrate, while POET captures recurring revenue and ecosystem leverage.

ARM's value came from being small and neutral, enabling multiple silicon partners and collecting royalties. If POET becomes the standard interposer architecture for co-packaged optics, its value may come not from a one-time acquisition premium, but from decades of licensing and system integration fees.

Why staying independent could be worth more

An acquisition often pays a near-term premium but destroys some long-term upside when the asset is absorbed. For a platform play, independence can preserve the neutral status that attracts customers across the industry.

Hyperscalers might prefer a neutral supplier they can partner with rather than a unit inside a competitor. That preference can boost licensing reach and long-term margin expansion, arguing for a valuation multiple well above a tactical strategic buyout.

"A neutral interposer that integrates optics and electronics at scale is uniquely valuable to hyperscalers, and that value is captured best as an independent platform," industry engineers and some buy-side investors have suggested.

Balanced risks

This optimistic path is not guaranteed. Execution risk is real, manufacturing yield and supply chain scale are hard, and competitors like Broadcom, Intel or in-house hyperscaler efforts could undercut POET's window.

Timing is another risk. Market adoption of co-packaged optics and if NVIDIA's co-packaged switches hit the market this year, it could accelerate demand, but if adoption stalls or alternative approaches win, the platform thesis weakens.

What investors should watch

• Quarterly cash burn and cash balance

• Validation milestones from LITEON and Lessengers, and shipment timing for the 1.6T samples (samples expected in Q2 2026).

• Customer qualification wins at hyperscalers and switch makers, especially any nonexclusive contracts.

• Competitive moves from large switch vendors and integrated optics suppliers.

POET sits at a strategic inflection point. The easiest story for Street chatter is an imminent acquisition, but the more consequential story may be that POET is better off unbought. If management executes, this small company could become a neutral backbone for co-packaged optics, a role that may command much higher multiples than any short-term buyout premium on the table today.

For investors and acquirers alike, the question is not just who will buy POET, but whether anyone should.